Table 4.
Group1 (n = 54) | Group2 (n = 85) | χ2 | P value | |
---|---|---|---|---|
ORR | 21/54 (38.90%) | 21/85 (24.70%) | 3.150 | 0.076 |
DCR | 50/54 (92.60%) | 63/85 (74.10%) | 7.412 | 0.006 |
Group1, lenvatinib plus sintilimab treatment group; Group2, lenvatinib monotherapy group.
Objective response rate (ORR); Disease Control Rate (DCR).